Target intelligence / Profile preview

Fungal cell wall component

Molecular classification
Other
01

Overview

Fungal cell wall component" is a broad term referring to the structural polysaccharides (primarily chitin, β-glucans, and mannans) and proteins that form a rigid, protective layer external to the plasma membrane of fungal cells[1][2][3][7]. This wall maintains cell shape, protects against environmental stresses, and can mediate immune evasion through masking of immunogenic moieties. Many clinically important antifungal drugs specifically target enzymes involved in the biosynthesis of these wall and membrane components, such as β-1,3-glucan synthase and ergosterol synthesis enzymes, because these molecules are not present in human cells[1][2][4][6]. While often listed as therapeutic targets, "fungal cell wall component" is not a singular, well-defined molecular entity, but encompasses multiple specific targets—such as β-1,3-glucan synthase or chitin synthase—each of which is associated with a distinct drug class or mechanism of action[2][4][6]. The fungal cell wall’s unique molecules are key for diagnosis (e.g. as biomarkers like serum β-D-glucan) and for the selective targeting required in antifungal therapy. **Note:** The entry "Fungal cell wall/membrane components" is too general and not a standard canonical target; for structured data, each specific component (e.g., "β-1,3-glucan synthase", "chitin synthase", "ergosterol") should be separately specified to align with drug targeting and biological function conventions[2][4][6].

Other names
Fungal cell wallFungal membrane componentFungal structural component
02

Mechanism of action

Inhibition of β-1,3-glucan synthesis (weakens cell wall); Inhibition of ergosterol synthesis (destabilizes cell membrane); Binding to ergosterol leading to membrane pore formation (causes cell leakage); Inhibition of chitin synthesis (compromises wall structure)

03

Biological functions

Structural integrityCellular protectionImmune evasionCell shape determinationRegulation of cell permeability
04

Disease associations

Infection
05

Safety considerations

Selectivity for fungal targets vs. human cells (off-target effects)Development of resistance (e.g., β-1,3-glucan synthase mutation)Toxicity of membrane-targeting drugs (e.g., amphotericin B nephrotoxicity)
06

Interacting drugs

Echinocandins (e.g., caspofungin, micafungin; target β-1,3-glucan synthase)

3 more in the full profile.

07

Biomarkers

Serum β-D-glucan (monitoring invasive fungal infections)Mannan antigens

Beyond the preview

Go deeper on Fungal cell wall component.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungal cell wall component.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call